TickerFacts.

QTREX Quantum Ltd. (QTEX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$9.96M
Year ended 2025-12-31
2021-12-31: -$6.87M2022-12-31: -$9.47M2023-12-31: -$9.90M2024-12-31: -$9.54M2025-12-31: -$9.96M-$9.96M
2021-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$9.96Mn/m2026-03-26, From 2025-01-01
2024-12-31-$9.54Mn/m2026-03-26, From 2024-01-01
2023-12-31-$9.90Mn/m2026-03-26, From 2023-01-01
2022-12-31-$9.47Mn/c2025-03-28, From 2022-01-01
2021-12-31-$6.87Mn/a2024-03-25, From 2021-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
QTREX Quantum Ltd. (QTEX)2025-12-31-$9.96Mn/m
Pulse Biosciences, Inc. (PLSE)2025-12-31-$54.44Mn/m
Co-Diagnostics, Inc. (CODX)2025-12-31-$29.84Mn/m
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2024-12-31-$4.85Mn/m
Catheter Precision, Inc. (VTAK)2025-12-31-$8.31Mn/m
Sintx Technologies, Inc. (SINT)2025-12-31-$8.76Mn/m
RenovoRx, Inc. (RNXT)2025-12-31-$10.97Mn/m
PetVivo Holdings, Inc. (PETV)2026-03-31-$6.12Mn/m
Vivos Inc (RDGL)2025-12-31-$2.16Mn/a

Compare QTEX, PLSE, CODX, HRGN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗